Korea/U.S. FTA may batter small and medium drug industries.

Published: 2006-04-21 06:59:00

Updated: 2006-04-21 06:59:00

Rep. Moon Hee of National Assembly Health and Welfare Committee and a member of the opposing Grand National Party said in the health and welfare committee's meeting on April 17 that the forthcoming Korea/U.S. FTA related with the health and medical matters should be cautiously undertook consideri...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK